The invention provides a
carbonyl reductase mutant. The
carbonyl reductase mutant is obtained by performing single-
point mutation or multi-point combined
mutation on the 17th site, the 40th site and the 64th site of an
amino acid sequence as shown in SEQ ID NO.1. The invention also provides a coding
gene, a recombinant vector containing the coding
gene, a co-expression
engineering bacterium and an application of the co-expression
engineering bacterium. Compared with a
wild type enzyme, the
carbonyl reductase mutant has
high activity and high
stereoselectivity, the
enzyme activity can reach more than two times that of the
wild type enzyme, the
catalytic efficiency on a substrate precursor
ketone is remarkably improved, the yield of a
statin drug intermediate and chiral
alcohol synthesized by an
enzyme method of the carbonyl
reductase mutant is remarkably improved, and the yield of a
rosuvastatin intermediate (3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R, 3R) is remarkably improved. The highest yields of the (3R, 5R)-6-chloro-3, 5-dihydroxyhexanoic acid tert-butyl ester and the
atorvastatin intermediate (3R, 5R)-6-cyano-3, 5-dihydroxyhexanoic acid tert-butyl ester reach 99% and 97.6% respectively, e.e. Is larger than 99%, and the method has high industrial application value.